Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial
Open Access
- 10 November 2017
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 70 (9) , 1320-1325
Abstract
Objective: To determine the symptom‐modifying effect of hydroxychloroquine (HCQ) in hand osteoarthritis (OA).Methods: In this randomized, double‐blind, multicenter trial, patients with symptomatic hand OA received either HCQ 400 mg once a day or placebo during 24 weeks. The primary outcome was change of pain measured on a 100‐mm visual analog scale (VAS) at 24 weeks. Secondary outcomes included decrease of pain at weeks 6 and 12 and change in Australian Canadian Hand Osteoarthritis Index (AUSCAN) and Arthritis Impact Measurement Scale 2 short form (AIMS2‐SF) total scores.Results: A total of 196 patients was included (placebo n = 98, HCQ n = 98). Mean ± SD age was 58.0 ± 7.6 years, and 86% were female. Baseline mean ± SD pain VAS was 44.9 ± 22.9 mm in the placebo group and 43.2 ± 22.3 mm in the HCQ group. At 24 weeks, change in pain VAS was not significantly different between both groups (imputed mean VAS 42.7 in the HCQ group versus 45.3 in the placebo group after 24 weeks), as was the case in pain VAS at weeks 6 and 12. Changes in AUSCAN total score and AIMS2‐SF total score in both groups were similar between the groups. In total, 24 patients in the placebo group and 21 patients in the HCQ group reported ≥1 adverse event. In the HCQ group, 3 patients reported a severe allergic reaction. Fifteen patients withdrew from the study (5 placebo, 10 HCQ group) due to adverse events.Conclusion: Treatment with HCQ at 24 weeks is not effective in reducing the symptoms of hand OA compared to placebo.Keywords
This publication has 25 references indexed in Scilit:
- Effectiveness of Triamcinolone Hexacetonide Intraarticular Injection in Interphalangeal Joints: A 12-week Randomized Controlled Trial in Patients with Hand OsteoarthritisThe Journal of Rheumatology, 2015
- Intra-Articular Corticosteroid Injections to Manage Trapeziometacarpal Osteoarthritis—a Systematic ReviewHAND, 2015
- OARSI guidelines for the non-surgical management of knee osteoarthritisOsteoarthritis and Cartilage, 2014
- Hand osteoarthritis—nonpharmacological and pharmacological treatmentsNature Reviews Rheumatology, 2014
- American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care & Research, 2012
- Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: A randomized, double‐blind, placebo‐controlled clinical trial at a single centerArthritis & Rheumatism, 2011
- EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2007
- Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioningAnnals of the Rheumatic Diseases, 2005
- Systematic review of therapies for osteoarthritis of the handOsteoarthritis and Cartilage, 2005
- Prevalence of Symptomatic Hand Osteoarthritis and Its Impact on Functional Status among the Elderly: The Framingham StudyAmerican Journal of Epidemiology, 2002